Skip to content

The effectiveness of ciprofol in inhibiting stress response during induction of general anesthesia

The effectiveness of ciprofol in inhibiting stress response during induction of general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076440
Enrollment
Unknown
Registered
2023-10-09
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative stress response

Interventions

Propofol group (P group):Anesthesia induction using propofol 1.5-2.5mg/kg, sufentanil 0.2-0.5ug/kg, and rocuronium 0.6mg/kg
Ciprofol group (C group) :Anesthesia induction using ciprofol 0.4mg/kg, sufentanil 0.2-0.5ug/kg, and rocuronium 0.6mg/kg

Sponsors

Gansu provincial hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age = 18 and = 60 years old Body mass index (BMI) = 18 and = 30kg/m2 ASA is classified as Grade I-II Patients who voluntarily participate in this trial and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Patients with asthma, hypertension, diabetes and coronary heart disease in the past Patients with severe liver and kidney dysfunction Patients who have been taking hormone drugs for a long time Patients who temporarily change their anesthesia methods due to various reasons Patients with difficulty in tracheal intubation

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure;Heart rate;Plasma cortisol;Plasma epinephrine;Plasma norepinephrine;

Secondary

MeasureTime frame
The incidence of hypotension;The incidence of bradycardia;The incidence of body moving;The incidence of choking cough;The incidence of tearing;Change amplitude of Ai value;Use of remedial anesthetics;Usage of vasoactive drugs;

Countries

China

Contacts

Public ContactReng dongqing

Gansu provincial hospital

rdqing30@126.com+86 181 9419 2927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026